Fan Pep's <4881> rose 176, up 17.

There has been a sudden surge. After the close of trading on the 7th, there was buying interest in anticipation of future progress as they announced their goal of starting phase 1 clinical trials for the developing allergy vaccine, 'FPP004X', in the first quarter of the fiscal year ending December 2025. The same company has signed an option contract for FPP004X with Shionogi & Co., Ltd., and holds the option right to acquire exclusive research and development and commercialization rights for all diseases worldwide.

J. Frontier <2934> rose 2675, up 412.

Surging. Welcia Pharmacy, which operates about 1,921 dispensing drugstores in 39 prefectures (as of April 15, 2024), has announced the introduction of its online medical treatment, medication guidance, and prescription drug delivery service "SOKUYAKU" for medical institutions and pharmacies in 19 prefectures with a positive view of this news.

Nulabo <5033> rose 940, up 32.

Continuing to rise. We have decided to hold parent-child events applying the project management concepts of our project and task management tool "Backlog" in 4 locations, Tokyo, Fukuoka, Osaka and Sapporo. "Backlog" is a collaboration type project management tool to advance work with team cooperation and can be used for a wide variety of purposes such as large-scale software development, operation and maintenance, digital marketing campaign management, website creation, and back office work. It has contributed to promoting collaboration among many teams since its release in 2005 and currently offers two types of cloud and on-premises versions and is used by over 1.2 million users worldwide.

Trace OP <6696> fell 595, down 91.

Significant decline. For the first quarter of the January 25th term, the ordinary loss is 8 million yen, and the deficit has narrowed (the same period last year was a deficit of 20 million yen). In the TRaaS business, we are actively promoting business with strategic sales partners, mainly focusing on SaaS monthly subscription-based businesses targeting retail stores, and the order-type product business is steadily progressing with STB projects. It was said that the order of system development projects is steadily progressing in technical service businesses, but disappointment sales due to the time required for business model transformation are leading.

Kuradashi <5884> rose 310, up 80.

Limit up. We have announced the introduction of a shareholder benefit system after closing on the 7th. The purpose is to deepen understanding of food loss issues and the business of shopping that contributes to society through shopping at the social good market "Kuradashi," which is our service, and to become fans of our company. We will present Kuradashi Gift Cards (worth 2,000 to 4,000 yen depending on the number of shares held) available for use at "Kuradashi" to shareholders who own 100 shares (1 unit) at the end of June each year.

Gumi <3903> fell 341, down 5.

The stock plummeted. The final profit and loss for the fiscal year ending April 24th, 2022 deteriorated to a deficit of 5.934 billion yen. Revenue losses from the mobile online game business, particularly from Aster Tatari Kusu, were bigger than anticipated, leading to significant operating losses, as well as one-time expenses due to the decision to cancel development of an original title in production. Already incurred expenses are expected to be borne by partners. In addition, the dividend payment for the end of the previous fiscal year, which had not been previously determined, was cancelled and the annual dividend for the current fiscal year is also undetermined. The FY 2025 earnings forecast was not disclosed.